arrow
S

Shu Yazaki

national cancer center research institute
H指数:6
被引数:110

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Germline variants of the POLH and RAD51 genes are candidate variants associated with risk of hormone receptor-negative young-onset breast cancer

POLH和RAD51基因的种系变异是激素受体阴性年轻发病乳腺癌风险的候选变异。

2025-11-280
OAAI
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine

eribulin或卡培他滨治疗HER2-null和HER2-low晚期乳腺癌的临床病理和预后特征

2024-08-142
OAAI
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy
2023-07-038
OAAI
Clinical evaluation of the efficacy and liquid molecular analysis of abemaciclib rechallenge upon progression to abemaciclib combination therapies for ER-positive HER2-negative metastatic breast cancer patients
2022-02-150
PRE